Clinically, G-CSF is administered to patients undergoing chemotherapy or bone marrow transplantation to reduce the risk of infection by boosting neutrophil production. It is also used to mobilize hematopoietic stem cells for collection in stem cell transplants. G-CSF preparations such as filgrastim and pegfilgrastim have become standard supportive care in oncology to manage chemotherapy-induced neutropenia.
